Hideyoshi Harashima

发表

Three-dimensional, symmetrically assembled microfluidic device for lipid nanoparticle production

M. Tokeshi, Masatoshi Maeki, A. Ishida, 2021, RSC advances.

A neutral lipid envelope-type nanoparticle composed of a pH-activated and vitamin E-scaffold lipid-like material as a platform for a gene carrier targeting renal cell carcinoma.

H. Harashima, H. Akita, H. Hatakeyama, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Development of Polymer-Lipid Hybrid Nanoparticles for Large-Sized Plasmid DNA Transfection.

Masatoshi Maeki, Yusuke Sato, Y. Fujioka, 2023, ACS applied materials & interfaces.

A Dual-Ligand Liposomal System Composed of a Cell-Penetrating Peptide and a Mitochondrial RNA Aptamer Synergistically Facilitates Cellular Uptake and Mitochondrial Targeting.

R. Furukawa, Hideyoshi Harashima, Yuma Yamada, 2016, Journal of pharmaceutical sciences.

Nano-Bio Interactions: Exploring the Biological Behavior and the Fate of Lipid-Based Gene Delivery Systems.

Seigo Kimura, Hideyoshi Harashima, 2024, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Incorporation of 8-hydroxyguanosine (8-oxo-7,8-dihydroguanosine) 5'-triphosphate by bacterial and human RNA polymerases.

Y. Yamaguchi, Hiroshi Handa, Hiroyuki Kamiya, 2009, Free radical biology & medicine.

Human cardiosphere-derived cells with activated mitochondria for better myocardial regenerative therapy.

A. Takeda, M. Shiraishi, Mitsue Hibino, 2024, Journal of controlled release : official journal of the Controlled Release Society.

Investigation of the Nanoparticulation Method and Cell-Killing Effect following the Mitochondrial Delivery of Hydrophobic Porphyrin-Based Photosensitizers

Masatoshi Maeki, Manabu Tokeshi, Hideyoshi Harashima, 2024, International journal of molecular sciences.

Application of apolipoprotein E-modified liposomal nanoparticles as a carrier for delivering DNA and nucleic acid in the brain

Yusuke Sato, H. Akita, H. Hatakeyama, 2014, International journal of nanomedicine.

The impact of, and expectations for, lipid nanoparticle technology: From cellular targeting to organelle targeting.

Takashi Nakamura, Yusuke Sato, Hideyoshi Harashima, 2024, Journal of controlled release : official journal of the Controlled Release Society.

Transient activation of transgene expression by hydrodynamics-based injection may cause rapid decrease in plasmid DNA expression

H. Yokosawa, Masahiro Fujimuro, Hideyoshi Harashima, 2007, Gene Therapy.

integrating both and

Y. Yasuzaki, R. Furukawa, Hideyoshi Harashima, 2022 .

Vaccination with a combination of STING agonist-loaded lipid nanoparticles and CpG-ODNs protects against lung metastasis via the induction of CD11bhighCD27low memory-like NK cells

Takashi Nakamura, Yusuke Sato, Hideyoshi Harashima, 2024, Experimental hematology & oncology.

π-extended porphyrin-based near-infrared photosensitizers for mitochondria-targeted photodynamic therapy

Y. Osakada, M. Fujitsuka, Hideyoshi Harashima, 2023, Journal of Photochemistry and Photobiology A: Chemistry.

Impact of Lipid Tail Length on the Organ Selectivity of mRNA-Lipid Nanoparticles

Yusuke Sato, Kazuki Hashiba, Masamitsu Taguchi, 2024, Nano letters.